Analysts from the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) reported today that overall tuberculosis (TB) incidence and mortality continue to decline throughout Europe, but trends among countries vary widely, and multidrug-resistant (MDR)-TB remains a major concern.

WHO officials say the data indicate that while the situation is improving in Europe, TB continues to be a major public health problem. They add that European health officials need to intensify their efforts if the region is to reach one of the milestones of the agency’s End TB strategy—an 80% reduction in the TB incidence rate by 2030 compared with 2015.

“TB is preventable and curable; the time to take action is now to end TB by 2030,” Zsuzsanna Jakab, MD, WHO regional director for Europe, said in an ECDC press release. “If we don’t act rapidly and decisively, the drug-resistant forms of the disease will increase their hold on Europe.”

Read more at CIDRAP…

See also:

Mar 19 WHO/ECDC TB surveillance and monitoring report

Mar 19 WHO/ECDC press release